Cancer risk in MLH1, MSH2 and MSH6 mutation carriers; different risk profiles may influence clinical management
-
* Corresponding author: Dewkoemar Ramsoekh d.ramsoekh@erasmusmc.nl
Hereditary Cancer in Clinical Practice 2009, 7:17 doi:10.1186/1897-4287-7-17
Pre-publication versions of this article and reviewers' reports
| Original Submission - Version 1 | Manuscript | 28 Jul 2009 | |
| Reviewer's Report | Allan Spigelman | 13 Aug 2009 | |
| Reviewer's Report | Carly Pouchet | 09 Sep 2009 | |
| Resubmission - Version 2 | Manuscript | Author's comment | 08 Oct 2009 |
| Editorial acceptance | 17 Oct 2009 | ||
| Published | 23 Dec 2009 |